NASDAQ : PPBT
Purple Biotech Ltd — Financial statements
Healthcare · Biotechnology · Israel
Last price 1.17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.49M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cost of Revenue | 59.00K | 59.00K | 62.00K | 196.00K | 120.00K | 55.00K |
| Gross Profit | -59.00K | -59.00K | -62.00K | -196.00K | -120.00K | -55.00K |
| Selling, General & Admin | 3.48M | 3.19M | 3.12M | 5.04M | 6.16M | 6.04M |
| Research & Development | 4.35M | 3.73M | 7.62M | 17.03M | 16.32M | 11.83M |
| Operating Expenses | 7.83M | 6.92M | 10.74M | 22.07M | 22.48M | 17.87M |
| Operating Income | -7.89M | -6.98M | -10.80M | -22.27M | -22.60M | -17.92M |
| Interest & Investment Income | 204.00K | 227.00K | 260.00K | 474.00K | 532.00K | 320.00K |
| Currency Exchange Gain (Loss) | 11.00K | 11.00K | -11.00K | -13.00K | 62.00K | -133.00K |
| Other Non Operating Income (Expenses) | 3.57M | 728.00K | 3.48M | 1.83M | 249.00K | -79.00K |
| EBT Excluding Unusual Items | -4.11M | -6.01M | -7.08M | -19.98M | -21.76M | -17.81M |
| Asset Writedown | -20.48M | -20.48M | -202.00K | |||
| Legal Settlements | -12.00K | |||||
| Pretax Income | -24.59M | -26.49M | -7.28M | -19.98M | -21.76M | -17.83M |
| Earnings From Continuing Operations | -24.59M | -26.49M | -7.28M | -19.98M | -21.76M | -17.83M |
| Earnings From Discontinued Operations | -642.00K | |||||
| Net Income to Company | -24.59M | -26.49M | -7.28M | -19.98M | -21.76M | -18.47M |
| Minority Interest in Earnings | 102.00K | 106.00K | 39.00K | 97.00K | 92.00K | 84.00K |
| Net Income | -24.49M | -26.39M | -7.24M | -19.88M | -21.67M | -18.38M |
| Net Income to Common | -24.49M | -26.39M | -7.24M | -19.88M | -21.67M | -18.38M |
| Shares Outstanding (Basic) | 1.70B | 960.11M | 327.91M | 221.33M | 180.81M | 175.68M |
| Shares Outstanding (Diluted) | 1.70B | 960.11M | 327.91M | 221.33M | 180.81M | 175.68M |
| EPS (Basic) | -0.01 | -0.03 | -0.02 | -0.09 | -0.12 | -0.10 |
| EPS (Diluted) | -0.01 | -0.03 | -0.02 | -0.09 | -0.12 | -0.10 |
| Free Cash Flow | -7.76M | -5.66M | -14.37M | -19.93M | -16.76M | -15.37M |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.04 | -0.09 | -0.09 | -0.09 |
| EBITDA | -7.84M | -6.97M | -10.77M | -22.07M | -22.40M | -17.69M |
| D&A For EBITDA | 46.00K | 3.00K | 34.00K | 197.00K | 201.00K | 231.00K |
| EBIT | -7.89M | -6.98M | -10.80M | -22.27M | -22.60M | -17.92M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.24M | 8.72M | 7.40M | 14.49M | 15.03M | 10.89M |
| Short-Term Investments | 869.00K | 857.00K | 1.12M | 923.00K | 17.08M | 36.31M |
| Cash & Short-Term Investments | 6.11M | 9.57M | 8.52M | 15.41M | 32.11M | 47.20M |
| Prepaid Expenses | 155.00K | 275.00K | 205.00K | 997.00K | 1.00M | |
| Other Current Assets | 485.00K | 137.00K | 109.00K | 171.00K | 146.00K | 268.00K |
| Total Current Assets | 6.59M | 9.87M | 8.91M | 15.79M | 33.26M | 48.47M |
| Property, Plant & Equipment | 216.00K | 346.00K | 288.00K | 470.00K | 682.00K | 896.00K |
| Long-Term Investments | 187.00K | |||||
| Other Intangible Assets | 7.36M | 7.36M | 27.84M | 28.04M | 20.68M | 20.48M |
| Other Long-Term Assets | 160.00K | |||||
| Total Assets | 14.17M | 17.57M | 37.04M | 44.30M | 54.62M | 70.20M |
| Accounts Payable | 487.00K | 2.07M | 1.46M | 3.53M | 2.13M | 1.47M |
| Accrued Expenses | 933.00K | 1.37M | 1.20M | 3.46M | 4.72M | 2.56M |
| Current Portion of Leases | 134.00K | 244.00K | 183.00K | 188.00K | 194.00K | 199.00K |
| Other Current Liabilities | 229.00K | 4.07M | 1.15M | 2.52M | 10.00K | 18.00K |
| Total Current Liabilities | 1.78M | 7.75M | 3.99M | 9.70M | 7.06M | 4.25M |
| Long-Term Leases | 163.00K | 321.00K | 550.00K | |||
| Pension & Post-Retirement Benefits | 170.00K | 160.00K | 140.00K | 141.00K | 145.00K | 292.00K |
| Total Liabilities | 1.95M | 7.91M | 4.13M | 10.01M | 7.52M | 5.09M |
| Additional Paid-In Capital | 155.83M | 152.48M | 147.63M | 133.18M | 126.41M | 123.95M |
| Retained Earnings | -170.72M | -171.08M | -144.69M | -137.45M | -117.57M | -95.91M |
| Comprehensive Income & Other | 27.16M | 28.31M | 29.92M | 38.48M | 38.08M | 36.78M |
| Total Common Equity | 12.27M | 9.71M | 32.86M | 34.21M | 46.91M | 64.83M |
| Minority Interest | -58.00K | -55.00K | 51.00K | 90.00K | 187.00K | 279.00K |
| Shareholders' Equity | 12.21M | 9.66M | 32.91M | 34.30M | 47.10M | 65.11M |
| Total Liabilities & Equity | 14.17M | 17.57M | 37.04M | 44.30M | 54.62M | 70.20M |
| Total Debt | 134.00K | 244.00K | 183.00K | 351.00K | 515.00K | 749.00K |
| Net Cash (Debt) | 5.97M | 9.33M | 8.34M | 15.06M | 31.60M | 46.45M |
| Net Cash Per Share | 0.00 | 0.01 | 0.03 | 0.07 | 0.17 | 0.26 |
| Filing Date Shares Outstanding | 2.17B | 1.86B | 529.64M | 265.58M | 207.87M | 178.26M |
| Total Common Shares Outstanding | 2.17B | 1.86B | 517.13M | 252.38M | 184.82M | 178.00M |
| Working Capital | 4.81M | 2.11M | 4.92M | 6.09M | 26.20M | 44.22M |
| Book Value Per Share | 0.01 | 0.01 | 0.06 | 0.14 | 0.25 | 0.36 |
| Tangible Book Value | 4.91M | 2.35M | 5.02M | 6.16M | 26.23M | 44.34M |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.14 | 0.25 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -24.49M | -26.39M | -7.24M | -19.88M | -21.67M | -18.38M |
| Depreciation & Amortization | 246.00K | 203.00K | 186.00K | 197.00K | 201.00K | 231.00K |
| Asset Writedown & Restructuring Costs | 20.48M | 20.48M | 202.00K | |||
| Stock-Based Compensation | 317.00K | 309.00K | 582.00K | 1.88M | 2.41M | 2.08M |
| Other Operating Activities | -3.88M | -1.07M | -3.77M | -2.39M | -935.00K | 450.00K |
| Change in Accounts Payable | -478.00K | 450.00K | -2.08M | 1.33M | 799.00K | 399.00K |
| Change in Other Net Operating Assets | 43.00K | 358.00K | -2.26M | -1.06M | 2.46M | 345.00K |
| Operating Cash Flow | -7.76M | -5.66M | -14.37M | -19.93M | -16.73M | -15.25M |
| Capital Expenditures | -4.00K | -3.00K | -3.00K | -26.00K | -115.00K | |
| Cash Acquisitions | -3.55M | |||||
| Sale (Purchase) of Intangibles | -202.00K | |||||
| Investment in Securities | 156.00K | 449.00K | 189.00K | 16.68M | 19.66M | 10.25M |
| Other Investing Activities | 162.00K | 186.00K | 320.00K | 755.00K | 484.00K | 3.27M |
| Investing Cash Flow | 314.00K | 632.00K | 509.00K | 13.88M | 19.91M | 13.41M |
| Long-Term Debt Repaid | -217.00K | -183.00K | -168.00K | -165.00K | -153.00K | |
| Lease Payments | -250.00K | -217.00K | -183.00K | -168.00K | -165.00K | -153.00K |
| Total Debt Repaid | -250.00K | -217.00K | -183.00K | -168.00K | -165.00K | -153.00K |
| Net Debt Issued (Repaid) | -250.00K | -217.00K | -183.00K | -168.00K | -165.00K | -153.00K |
| Issuance of Common Stock | 4.79M | 3.15M | 7.84M | 1.56M | 1.50M | 1.76M |
| Other Financing Activities | 3.38M | 3.40M | -880.00K | 4.05M | -219.00K | -99.00K |
| Financing Cash Flow | 7.92M | 6.33M | 6.77M | 5.45M | 1.11M | 1.51M |
| Foreign Exchange Rate Adjustments | 26.00K | 7.00K | -4.00K | 54.00K | -153.00K | -24.00K |
| Net Cash Flow | 500.00K | 1.32M | -7.09M | -541.00K | 4.14M | -357.00K |
| Free Cash Flow | -7.76M | -5.66M | -14.37M | -19.93M | -16.76M | -15.37M |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.04 | -0.09 | -0.09 | -0.09 |
| Levered Free Cash Flow | -4.90M | -54.00K | -11.70M | -8.43M | -8.80M | -7.64M |
| Unlevered Free Cash Flow | -4.90M | -54.00K | -11.70M | -8.43M | -8.80M | -7.64M |
| Free Cash Flow After Leases | -8.01M | -5.88M | -14.55M | -20.10M | -16.93M | -15.52M |
| Cash Interest Paid | 9.00K | 23.00K | 44.00K | 56.00K | 67.00K | 75.00K |
| Change in Working Capital | -435.00K | 808.00K | -4.33M | 274.00K | 3.25M | 744.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 10.49M | 7.00M | 11.07M | 21.67M | 26.83M | 68.39M |
| Enterprise Value | 4.68M | -3.55M | 4.93M | 5.15M | -5.90M | 22.23M |
| Last Close Price | 1.17 | 6.58 | 46.90 | 156.00 | 276.00 | 778.00 |
| PB Ratio | 0.86 | 0.72 | 0.34 | 0.63 | 0.57 | 1.05 |
| P/TBV Ratio | 2.13 | 2.97 | 2.21 | 3.52 | 1.02 | 1.54 |
| Debt / Equity Ratio | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -0.49 | -0.97 | -0.25 | -0.44 | -0.67 | -0.71 |
| Net Debt / EBITDA Ratio | 0.76 | 1.34 | 0.78 | 0.68 | 1.41 | 2.63 |
| Net Debt / FCF Ratio | 0.77 | 1.65 | 0.58 | 0.76 | 1.89 | 3.02 |
| Quick Ratio | 3.42 | 1.24 | 2.14 | 1.59 | 4.55 | 11.11 |
| Current Ratio | 3.70 | 1.27 | 2.23 | 1.63 | 4.71 | 11.40 |
| Return on Equity (ROE) | -111.13% | -124.46% | -21.66% | -49.09% | -38.79% | -24.61% |
| Return on Assets (ROA) | -20.31% | -15.97% | -16.60% | -28.14% | -22.63% | -14.55% |
| Return on Capital Employed (ROCE) | -63.70% | -71.00% | -32.70% | -64.40% | -47.50% | -27.20% |
| Earnings Yield | -429.08% | -377.18% | -65.38% | -91.76% | -80.75% | -26.88% |
| FCF Yield | -74.03% | -80.89% | -129.73% | -91.98% | -62.47% | -22.47% |
| Buyback Yield / Dilution | -267.67% | -192.79% | -48.15% | -22.41% | -2.92% | -52.76% |